Increased Serum 90K and Galectin-3 Expression Are Associated with Advanced Stage and a Worse Prognosis in Diffuse Large B-Cell Lymphomas

Publisher： Karger

E-ISSN： 1421-9662|120|4|211-216

ISSN： 0001-5792

Source： Acta Haematologica, Vol.120, Iss.4, 2009-01, pp. : 211-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MYC protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 7, 2015-07 ,pp. : 596-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apoptosis-Regulating Proteins and Prognosis in Diffuse Large B Cell Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 107, Iss. 1, 2002-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Consolidation Radiotherapy to Bulky or Semibulky Lesions in the Management of Stage III–IV Diffuse Large B Cell Lymphomas

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 219-226

Karger

Access to resources Recommend Favorite

Immunohistochemical Expression of Multidrug Resistance Proteins as a Predictor of Poor Response to Chemotherapy and Prognosis in Patients with Nodal Diffuse Large B-Cell Lymphoma

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 422-431

Karger

Access to resources Recommend Favorite

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 278, Iss. 3, 2015-09 ,pp. : 323-332

John Wiley & Sons Inc

Access to resources Recommend Favorite